| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZEPBOUND KWIKPEN | 217806 | 019 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 10MG/2.4ML (4.17MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |
| ZEPBOUND KWIKPEN | 217806 | 020 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 20MG/2.4ML (8.33MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |
| ZEPBOUND KWIKPEN | 217806 | 021 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 30MG/2.4ML (12.5MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |
| ZEPBOUND KWIKPEN | 217806 | 022 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 40MG/2.4ML (16.7MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |
| ZEPBOUND KWIKPEN | 217806 | 023 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 50MG/2.4ML (20.8MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |
| ZEPBOUND KWIKPEN | 217806 | 024 | NDA | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 60MG/2.4ML (25MG/ML) | Yes | Yes | 2023/11/08 | 2026/01/20 | ELI LILLY AND CO | Prescription |